Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-11 @ 11:57 AM
Study NCT ID:
NCT02675959
Status:
RECRUITING
Last Update Posted:
2025-05-23
First Post:
2016-01-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Sponsor:
New York Medical College
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NYMC 571
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None